Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Juno Therapeutics (JUNO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,096,926
  • Shares Outstanding, K 116,110
  • Annual Sales, $ 79,360 K
  • Annual Income, $ -245,580 K
  • 36-Month Beta 3.24
  • Price/Sales 82.93
  • Price/Cash Flow N/A
  • Price/Book 9.58
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.25
  • Most Recent Earnings -0.73 on 11/01/17
  • Next Earnings Date 03/07/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.77 +2.58%
on 02/20/18
87.01 -0.06%
on 03/05/18
+1.34 (+1.57%)
since 02/05/18
3-Month
42.29 +105.63%
on 12/19/17
87.01 -0.06%
on 03/05/18
+33.76 (+63.46%)
since 12/05/17
52-Week
19.62 +343.22%
on 03/27/17
87.01 -0.06%
on 03/05/18
+65.35 (+302.41%)
since 03/03/17

Most Recent Stories

More News
Celgene Corporation Announces Changes to Its Board of Directors

--US health insurance expert Patricia Hemingway Hall elected to Board of Directors

CELG : 88.95 (-0.75%)
CELGZ : 0.25 (+19.05%)
JUNO : 86.96 (+0.10%)
78.2% Return Seen to Date on SmarTrend Juno Therapeutic Call (JUNO)

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 3 months, Juno Therapeutic has returned 78.23% as of today's recent price of $86.96....

JUNO : 86.96 (+0.10%)
Uptrend Call Working As Juno Therapeutic Stock Rises 78.2% (JUNO)

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 3 months, Juno Therapeutic has returned 78.23% as of today's recent price of $86.96....

JUNO : 86.96 (+0.10%)
Juno Therapeutic Shares Up 78.2% Since SmarTrend's Buy Recommendation (JUNO)

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 3 months, Juno Therapeutic has returned 78.23% as of today's recent price of $86.96....

JUNO : 86.96 (+0.10%)
These Biotech Stocks Have a Strong Green Close on Friday

CORAL GABLES, FL / ACCESSWIRE / March 29, 2018 / The biotechnology industry continued to recover on Thursday. The market itself had one of its most volatile weeks yet as the first quarter of 2018 came...

GALT : 3.46 (-5.72%)
GTBP : 1.6400 (-1.20%)
CELGZ : 0.25 (+19.05%)
JUNO : 86.96 (+0.10%)
Pomerantz LLP Announces Pendency of Class Action Lawsuit Involving Purchasers of Juno Therapeutics, Inc. Common Stock

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WASHINGTON AT SEATTLE

JUNO : 86.96 (+0.10%)
Juno Therapeutic Has Returned 78.2% Since SmarTrend Recommendation (JUNO)

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 3 months, Juno Therapeutic has returned 78.23% as of today's recent price of $86.96....

JUNO : 86.96 (+0.10%)
78.2% Return Seen to Date on SmarTrend Juno Therapeutic Call (JUNO)

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 2 months, Juno Therapeutic has returned 78.23% as of today's recent price of $86.96....

JUNO : 86.96 (+0.10%)
Zacks Investment Ideas feature highlights: Sangamo, bluebird, Editas, Sarepta and Juno

Zacks Investment Ideas feature highlights: Sangamo, bluebird, Editas, Sarepta and Juno

SGMO : 19.05 (-0.78%)
BLUE : 170.50 (unch)
SRPT : 79.99 (+1.83%)
EDIT : 34.46 (-1.01%)
JUNO : 86.96 (+0.10%)
Zacks Industry Outlook Highlights: Sanofi, Celgene, Bioverativ, Juno and Merck

Zacks Industry Outlook Highlights: Sanofi, Celgene, Bioverativ, Juno and Merck

CELG : 88.95 (-0.75%)
MRK : 58.83 (+0.32%)
BIVV : 104.98 (+0.32%)
JUNO : 86.96 (+0.10%)
SNY : 39.96 (-0.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Juno Therapeutics, Inc. is a biopharmaceutical company. The Company develops cellular immunotherapies based on two platforms - Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. Its clinical CD19 product candidates include JCAR015 that is in Phase I clinical trials for adult...

See More

Key Turning Points

2nd Resistance Point 87.07
1st Resistance Point 87.01
Last Price 86.96
1st Support Level 86.90
2nd Support Level 86.85

See More

52-Week High 87.01
Last Price 86.96
Fibonacci 61.8% 61.27
Fibonacci 50% 53.32
Fibonacci 38.2% 45.36
52-Week Low 19.62

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar